JP2014530242A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530242A5 JP2014530242A5 JP2014535953A JP2014535953A JP2014530242A5 JP 2014530242 A5 JP2014530242 A5 JP 2014530242A5 JP 2014535953 A JP2014535953 A JP 2014535953A JP 2014535953 A JP2014535953 A JP 2014535953A JP 2014530242 A5 JP2014530242 A5 JP 2014530242A5
- Authority
- JP
- Japan
- Prior art keywords
- topical formulation
- formulation according
- ointment
- topical
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161546833P | 2011-10-13 | 2011-10-13 | |
| US61/546,833 | 2011-10-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014530242A JP2014530242A (ja) | 2014-11-17 |
| JP2014530242A5 true JP2014530242A5 (enExample) | 2015-12-03 |
Family
ID=48082531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014535953A Pending JP2014530242A (ja) | 2011-10-13 | 2012-10-12 | 皮膚疾病の処置用のケメリンｃ１５ペプチドの局所製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20140349943A1 (enExample) |
| EP (1) | EP2766032A4 (enExample) |
| JP (1) | JP2014530242A (enExample) |
| CN (1) | CN104159594A (enExample) |
| AU (1) | AU2012323952A1 (enExample) |
| CA (1) | CA2851643A1 (enExample) |
| HK (1) | HK1202064A1 (enExample) |
| WO (1) | WO2013056147A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011072141A1 (en) | 2009-12-11 | 2011-06-16 | Neuron Systems, Inc. | Compositions and methods for the treatment of macular degeneration |
| SG11201505587YA (en) | 2013-01-23 | 2015-08-28 | Aldeyra Therapeutics Inc | Toxic aldehyde related diseases and treatment |
| WO2014168721A2 (en) * | 2013-04-12 | 2014-10-16 | Tufts Medical Center | Methods and systems for designing and/or characterizing soluble lipidated ligand agents |
| CN103432073A (zh) * | 2013-09-11 | 2013-12-11 | 中国药科大学 | 一种肿瘤靶向纳米制剂及其制备方法 |
| EP3126004A4 (en) * | 2014-04-02 | 2017-11-29 | Rogne Bioscience Inc. | Methods and compositions for treating inflammatory disorders |
| JP6719181B2 (ja) * | 2015-07-16 | 2020-07-08 | 花王株式会社 | 皮膚化粧料 |
| AU2016311158A1 (en) | 2015-08-21 | 2018-04-05 | Aldeyra Therapeutics, Inc. | Deuterated compounds and uses thereof |
| CN105277194B (zh) * | 2015-10-12 | 2019-01-08 | 南京信息工程大学 | 一种基于云平台的室内交互式引导实现方法 |
| WO2017127827A1 (en) * | 2016-01-22 | 2017-07-27 | Tufts Medical Center | Compounds and methods for treating inflammation |
| WO2017168416A1 (en) * | 2016-03-28 | 2017-10-05 | Vidac Pharma Ltd. | Stable pharmaceutical compositions for topical administration and uses thereof |
| MX2020003425A (es) | 2017-10-10 | 2020-07-29 | Aldeyra Therapeutics Inc | Tratamiento de trastornos inflamatorios. |
| CN108192866B (zh) * | 2018-03-07 | 2021-05-11 | 郑州大学第一附属医院 | Sfn联合il-15和il-21制备记忆性t细胞的方法及应用 |
| US20200038392A1 (en) * | 2018-08-03 | 2020-02-06 | Aldeyra Therapeutics, Inc. | Topical compositions and methods of preparation and use |
| EP3833660A4 (en) | 2018-08-06 | 2022-05-11 | Aldeyra Therapeutics, Inc. | POLYMORPHIC COMPOUNDS AND THEIR USES |
| CN109096368B (zh) * | 2018-09-30 | 2021-07-20 | 华南理工大学 | 一种同时具有抗氧化和护肝活性的多肽及编码该多肽的基因与其制备方法和应用 |
| MX2021009602A (es) * | 2019-03-06 | 2021-09-08 | Isdin Sa | Uso de trigliceridos caprilicos y capricos para el tratamiento de una enfermedad o afeccion mediada por deficiencia de filagrina o colageno. |
| JP2022530967A (ja) | 2019-05-02 | 2022-07-05 | アルデイラ セラピューティクス， インコーポレイテッド | 多形化合物およびその使用 |
| US11730705B2 (en) | 2019-05-02 | 2023-08-22 | The Board Of Trustees Of The Leland Stanford Junior University | Small molecule CMKLR1 antagonists in inflammatory disease |
| US12098132B2 (en) | 2019-05-02 | 2024-09-24 | Aldeyra Therapeutics, Inc. | Process for preparation of aldehyde scavenger and intermediates |
| KR20230051117A (ko) * | 2020-01-10 | 2023-04-17 | 브리오리 바이오테크 인코포레이티드 | 로페콕시브를 함유하는 국소 조성물 및 이의 제조 및 사용 방법 |
| CA3175856A1 (en) | 2020-05-13 | 2021-11-18 | Todd Brady | Pharmaceutical formulations and uses thereof |
| CA3191321A1 (en) * | 2020-08-12 | 2022-02-17 | Bayer Aktiengesellschaft | Cyclic chemerin-9 derivatives |
| CN112190687B (zh) * | 2020-11-19 | 2022-06-10 | 温州医科大学附属第一医院 | 一种用于减少皮肤创伤瘢痕的药物及其应用 |
| CN112881668B (zh) * | 2021-01-18 | 2022-04-12 | 江苏省中医院 | 两种血清代谢物单独或联合用于制备诊断干燥综合征的试剂盒的用途 |
| US20240197619A1 (en) * | 2022-12-14 | 2024-06-20 | Alicia Marie Santino Turnbull | Ointment or Balm and Method for Producing Same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7419658B2 (en) * | 2001-07-09 | 2008-09-02 | Euroscreen S.A. | Isolated ligand of ChemerinR |
| AU2003274076A1 (en) * | 2002-10-31 | 2004-05-25 | Ipf Pharmaceuticals Gmbh | Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| GB0705488D0 (en) * | 2007-03-22 | 2007-05-02 | Isis Innovation | Treatment of inflammation and/or endotoxic shock |
| WO2009139817A2 (en) * | 2008-04-15 | 2009-11-19 | Sarcode Corporation | Crystalline pharmaceutical and methods of preparation and use thereof |
| US20100041603A1 (en) * | 2008-05-16 | 2010-02-18 | Corthera, Inc. | Method of Promoting Wound Healing |
| KR101559068B1 (ko) * | 2008-08-27 | 2015-10-20 | (주)아모레퍼시픽 | 키메린을 함유하는 지방세포 분화 억제 및 지방세포 내의 지질체 수준 감소용 조성물 |
| US20100092546A1 (en) * | 2008-10-10 | 2010-04-15 | Gurtner Geoffrey C | Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds |
-
2012
- 2012-10-12 US US14/352,296 patent/US20140349943A1/en not_active Abandoned
- 2012-10-12 WO PCT/US2012/060093 patent/WO2013056147A1/en not_active Ceased
- 2012-10-12 EP EP12839527.4A patent/EP2766032A4/en not_active Withdrawn
- 2012-10-12 CA CA2851643A patent/CA2851643A1/en not_active Abandoned
- 2012-10-12 CN CN201280061652.5A patent/CN104159594A/zh active Pending
- 2012-10-12 HK HK15102607.4A patent/HK1202064A1/xx unknown
- 2012-10-12 AU AU2012323952A patent/AU2012323952A1/en not_active Abandoned
- 2012-10-12 JP JP2014535953A patent/JP2014530242A/ja active Pending
-
2015
- 2015-12-29 US US14/983,069 patent/US20160136231A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530242A5 (enExample) | ||
| AR124134A2 (es) | Formulación de uso tópico para un inhibidor de jak | |
| WO2009053741A3 (en) | Novel formulation | |
| JP2015522049A5 (enExample) | ||
| CL2019002172A1 (es) | Agente terapéutico para enfermedades del hígado. | |
| JP2013515002A5 (enExample) | ||
| AR070047A1 (es) | Tratamientos terapeuticos contra el cancer. composicion que comprende un inhibidor de hedgehog. | |
| AR090349A1 (es) | Terapia de combinacion para trastornos proliferativos, kit y uso | |
| JP2012531448A5 (enExample) | ||
| JP2016512246A5 (enExample) | ||
| JP2002526407A5 (enExample) | ||
| WO2013022243A3 (ko) | 신규한 바이페닐 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 염증성 질환 또는 자가면역질환의 예방 또는 치료용 약학적 조성물 | |
| JP2019524774A5 (enExample) | ||
| JP2012508256A5 (enExample) | ||
| JP2013520448A5 (enExample) | ||
| JP2010510194A5 (enExample) | ||
| CN105125445A (zh) | 一种牙膏组合物 | |
| RU2012149868A (ru) | Полисахарид семян для применения в лечении воспалительных заболеваний | |
| JP2012525358A5 (enExample) | ||
| JP2016538288A5 (enExample) | ||
| WO2016181355A1 (en) | Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity | |
| MX2011010785A (es) | Crema medicinal para dermatitis del pañal incorporando un biopolimero y el proceso para hacerla. | |
| RU2019102890A (ru) | Фармацевтические композиции, содержащие флурбипрофен | |
| RU2013142445A (ru) | Фармацевтический препарат для местного применения, содержащий в-220 | |
| NZ606177A (en) | Compositions for the treatment of actinic keratosis |